{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:33:12Z","timestamp":1758774792715,"version":"3.44.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.ygyno.2021.05.019","type":"journal-article","created":{"date-parts":[[2021,5,29]],"date-time":"2021-05-29T23:31:48Z","timestamp":1622331108000},"page":"315-321","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Cervical testing beyond the screening target age \u2013 A register-based cohort study from Finland"],"prefix":"10.1016","volume":"162","author":[{"given":"Natalie","family":"Keltto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aku","family":"Leivonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maiju","family":"Pankakoski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tytti","family":"Sarkeala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sirpa","family":"Hein\u00e4vaara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahti","family":"Anttila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2005","series-title":"Cervix Cancer Screening","author":"Working Group on the Evaluation of Cancer Preventive Agents","key":"10.1016\/j.ygyno.2021.05.019_bb0005"},{"issue":"3","key":"10.1016\/j.ygyno.2021.05.019_bb0010","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1093\/annonc\/mdp471","article-title":"European guidelines for quality assurance in cervical cancer screening. Second edition\u2014summary document","volume":"21","author":"Arbyn","year":"2010","journal-title":"Ann. Oncol."},{"year":"2017","series-title":"Cancer Screening in the European Union: Report on the Implementation of the Council Recommendation on Cancer Screening","author":"Ponti","key":"10.1016\/j.ygyno.2021.05.019_bb0015"},{"issue":"1","key":"10.1016\/j.ygyno.2021.05.019_bb0020","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/ijc.28646","article-title":"Divergent coverage, frequency and costs of organised and opportunistic Pap testing in Finland: coverage, frequency and costs of Pap testing","volume":"135","author":"Salo","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2021.05.019_bb0025","doi-asserted-by":"crossref","first-page":"106219","DOI":"10.1016\/j.ypmed.2020.106219","article-title":"Differences in cervical test coverage by age, socioeconomic status, ethnic origin and municipality type \u2013 a nationwide register-based study","volume":"139","author":"Pankakoski","year":"2020","journal-title":"Prev. Med."},{"year":"2015","series-title":"European Guidelines for Quality Assurance in Cervical Cancer Screening","key":"10.1016\/j.ygyno.2021.05.019_bb0030"},{"issue":"7","key":"10.1016\/j.ygyno.2021.05.019_bb0035","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1001\/jama.2018.10400","article-title":"Screening for cervical cancer with high-risk human papillomavirus testing: updated evidence report and systematic review for the US preventive services task force","volume":"320","author":"Melnikow","year":"2018","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.ygyno.2021.05.019_bb0040","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jama.2018.10897","article-title":"Screening for cervical cancer: US preventive services task force recommendation statement","volume":"320","author":"US Preventive Services Task Force","year":"2018","journal-title":"JAMA"},{"author":"Kohdunkaulan","key":"10.1016\/j.ygyno.2021.05.019_bb0045"},{"key":"10.1016\/j.ygyno.2021.05.019_bb0050","series-title":"The European Cancer Information System (ECIS) Web Application","first-page":"27","author":"Randi","year":"2018"},{"year":"26032019","series-title":"NORDCAN: Cancer Incidence, Mortality, Prevalence and Survival in the Nordic Countries, Version 8.2","author":"Danckert","key":"10.1016\/j.ygyno.2021.05.019_bb0055"},{"issue":"3","key":"10.1016\/j.ygyno.2021.05.019_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0214486","article-title":"Effectiveness of cervical cancer screening at age 65 \u2014 a register-based cohort study","volume":"14","author":"Pankakoski","year":"2019","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.ygyno.2021.05.019_bb0065","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1158\/1055-9965.EPI-12-0162","article-title":"Age-specific effectiveness of the Finnish cervical cancer screening programme","volume":"21","author":"Lonnberg","year":"2012","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"2","key":"10.1016\/j.ygyno.2021.05.019_bb0070","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ygyno.2014.02.037","article-title":"The association between cervical cancer screening and mortality from cervical cancer: a population based case\u2013control study","volume":"133","author":"Vicus","year":"2014","journal-title":"Gynecol. Oncol."},{"issue":"9","key":"10.1016\/j.ygyno.2021.05.019_bb0075","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1002\/ijc.27844","article-title":"Mortality audit of the Finnish cervical cancer screening program","volume":"132","author":"L\u00f6nnberg","year":"2013","journal-title":"Int. J. Cancer"},{"author":"Finnish Cancer Registry","key":"10.1016\/j.ygyno.2021.05.019_bb0080"},{"issue":"9","key":"10.1016\/j.ygyno.2021.05.019_bb0085","first-page":"1653","article-title":"Efficacy of screening in preventing cervical cancer among older women","volume":"24","author":"Kamineni","year":"2013","journal-title":"Cancer Causes Control"},{"issue":"9","key":"10.1016\/j.ygyno.2021.05.019_bb0090","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/aje\/kwu035","article-title":"Cervical screening and cervical cancer death among older women: a population-based, Case-control study","volume":"179","author":"Rustagi","year":"2014","journal-title":"Am. J. Epidemiol."},{"issue":"3","key":"10.1016\/j.ygyno.2021.05.019_bb0095","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ygyno.2016.06.016","article-title":"Case-control study of cervical cancer and gynecologic screening: a SEER-Medicare analysis","volume":"142","author":"Rosenblatt","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2021.05.019_bb0100","doi-asserted-by":"crossref","first-page":"i276","DOI":"10.1136\/bmj.i276","article-title":"Risk of invasive cervical cancer after atypical glandular cells in cervical screening: nationwide cohort study","volume":"11","author":"Wang","year":"2016","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.ygyno.2021.05.019_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002414","article-title":"Effectiveness of cervical screening after age 60 years according to screening history: nationwide cohort study in Sweden","volume":"14","author":"Wang","year":"2017","journal-title":"PLoS Med."},{"issue":"7629","key":"10.1016\/j.ygyno.2021.05.019_bb0110","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1136\/bmj.39363.471806.BE","article-title":"Long term risk of invasive cancer after treatment for cervical intraepithelial neoplasia grade 3: population based cohort study","volume":"335","author":"Strander","year":"2007","journal-title":"BMJ."},{"issue":"1","key":"10.1016\/j.ygyno.2021.05.019_bb0115","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.whi.2017.10.010","article-title":"Women\u2019s behaviors toward mammogram and pap test: opportunities to increase cervical cancer screening participation rates among older women","volume":"28","author":"Tavasoli","year":"2018","journal-title":"Womens Health Issues"},{"issue":"6","key":"10.1016\/j.ygyno.2021.05.019_bb0120","doi-asserted-by":"crossref","first-page":"E677","DOI":"10.1002\/ijc.29176","article-title":"Improving cervical cancer screening attendance in Finland: improving cervical cancer screening attendance","volume":"136","author":"Virtanen","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2021.05.019_bb0125","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.puhe.2017.12.014","article-title":"Sociodemographic and lifestyle determinants of non-attendance for cervical cancer screening in Lithuania, 2006\u20132014","volume":"156","author":"Petkeviciene","year":"2018","journal-title":"Public Health"},{"key":"10.1016\/j.ygyno.2021.05.019_bb0130","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ypmed.2016.11.018","article-title":"Personal and provider level factors influence participation to cervical cancer screening: a retrospective register-based study of 1.3 million women in Norway","volume":"94","author":"Leinonen","year":"2017","journal-title":"Prev. Med."},{"issue":"2","key":"10.1016\/j.ygyno.2021.05.019_bb0135","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.canep.2013.12.007","article-title":"Predictors of non-participation in cervical screening in Denmark","volume":"38","author":"Kristensson","year":"2014","journal-title":"Cancer Epidemiol."},{"issue":"1","key":"10.1016\/j.ygyno.2021.05.019_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0190171","article-title":"Socio-economic and demographic determinants affecting participation in the Swedish cervical screening program: a population-based case-control study","volume":"13","author":"Broberg","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ygyno.2021.05.019_bb0145","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/1471-2458-11-264","article-title":"Factors associated with non-attendance, opportunistic attendance and reminded attendance to cervical screening in an organized screening program: a cross-sectional study of 12,058 Norwegian women","volume":"11","author":"Hansen","year":"2011","journal-title":"BMC Public Health"},{"issue":"15","key":"10.1016\/j.ygyno.2021.05.019_bb0150","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1016\/j.ejca.2009.07.020","article-title":"Cervical cancer screening policies and coverage in Europe","volume":"45","author":"Anttila","year":"2009","journal-title":"Eur. J. Cancer"},{"author":"Statistics Finland","key":"10.1016\/j.ygyno.2021.05.019_bb0155"},{"issue":"7526","key":"10.1016\/j.ygyno.2021.05.019_bb0160","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1136\/bmj.38663.459039.7C","article-title":"Risk of cervical and other cancers after treatment of cervical intraepithelial neoplasia: retrospective cohort study","volume":"331","author":"Kalliala","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.ygyno.2021.05.019_bb0165","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b1354","article-title":"Incidence of cervical cancer after several negative smear results by age 50: prospective observational study","volume":"338","author":"Rebolj","year":"2009","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.ygyno.2021.05.019_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001585","article-title":"Cervical screening at age 50\u201364 years and the risk of cervical cancer at age 65 years and older: population-based case control study","volume":"11","author":"Casta\u00f1\u00f3n","year":"2014","journal-title":"PLoS Med."},{"issue":"4","key":"10.1016\/j.ygyno.2021.05.019_bb0175","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00432-008-0485-0","article-title":"Socio-demographic characteristics of participation in the opportunistic German cervical cancer screening programme: results from the EPIC-Heidelberg cohort","volume":"135","author":"Seidel","year":"2009","journal-title":"J. Cancer Res. Clin. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082582100425X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082582100425X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:56:28Z","timestamp":1758772588000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009082582100425X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S009082582100425X"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2021.05.019","relation":{},"ISSN":["0090-8258"],"issn-type":[{"type":"print","value":"0090-8258"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cervical testing beyond the screening target age \u2013 A register-based cohort study from Finland","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2021.05.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}